ArticleJournal of proteome research2013

HR-MAS NMR tissue metabolomic signatures cross-validated by mass spectrometry distinguish bladder cancer from benign disease.

Pratima Tripathi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.